 Contraceptive Agents, Female
"Contraceptive Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
| Descriptor ID |
D003271
|
| MeSH Number(s) |
D27.505.696.875.360.276 D27.505.954.705.360.276
|
| Concept/Terms |
Contraceptive Agents, Female- Contraceptive Agents, Female
- Agents, Female Contraceptive
- Female Contraceptive Agents
- Contraceptives, Female
- Female Contraceptives
|
Below are MeSH descriptors whose meaning is more general than "Contraceptive Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Contraceptive Agents, Female".
This graph shows the total number of publications written about "Contraceptive Agents, Female" by people in this website by year, and whether "Contraceptive Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 3 | 0 | 3 | | 2013 | 2 | 0 | 2 | | 2014 | 4 | 0 | 4 | | 2015 | 3 | 0 | 3 | | 2016 | 3 | 2 | 5 | | 2017 | 3 | 1 | 4 | | 2018 | 1 | 2 | 3 | | 2019 | 3 | 1 | 4 | | 2020 | 6 | 0 | 6 | | 2021 | 7 | 0 | 7 | | 2022 | 2 | 0 | 2 | | 2023 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Contraceptive Agents, Female" by people in Profiles.
-
Diamond B, Sheeder J, Lazorwitz A. An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users. Contraception. 2024 01; 129:110298.
-
Lazorwitz A, Sheeder J, Teal S. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study. Contraception. 2023 07; 123:110035.
-
Wilde M, Moyer G, Huguelet PS. Use of the Levonorgestrel Intrauterine Device in an Adolescent with Type IV Vascular Ehlers-Danlos Syndrome and Heavy Menstrual Bleeding, a Case Report. J Pediatr Adolesc Gynecol. 2023 Jun; 36(3):331-333.
-
Fang NZ, Westhoff CL. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States. Am J Obstet Gynecol. 2022 09; 227(3):477.e1-477.e7.
-
Lazorwitz A, Pena M, Sheeder J, Teal S. Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users. Obstet Gynecol. 2022 04 01; 139(4):579-587.
-
Lazorwitz A, Sheeder J, Teal S. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period. Contraception. 2022 04; 108:65-68.
-
Friedman JC, Buyers E, Laurin J, Hampanda K, Alaniz VI. Tamoxifen for the Treatment of Etonogestrel Implant-Associated Bleeding in an Adolescent Gynecology Practice. J Pediatr Adolesc Gynecol. 2022 Jun; 35(3):341-345.
-
Huguelet PS, Laurin JL, Thornhill D, Moyer G. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2022 Apr; 35(2):147-152.e1.
-
Batt CE, Sheeder J, Love-Osborne K. Weight Gain Patterns in Adolescent and Young Adult Women With the Etonogestrel Implant: Comparison by Weight Category. J Adolesc Health. 2021 11; 69(5):815-823.
-
Lew J, Sheeder J, Lazorwitz A. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients. Contraception. 2021 11; 104(5):556-560.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|